DE69232535D1 - LONG-TERM CULTURE HORMONE-SECONDING PANCREATIC CELLS - Google Patents
LONG-TERM CULTURE HORMONE-SECONDING PANCREATIC CELLSInfo
- Publication number
- DE69232535D1 DE69232535D1 DE69232535A DE69232535A DE69232535D1 DE 69232535 D1 DE69232535 D1 DE 69232535D1 DE 69232535 A DE69232535 A DE 69232535A DE 69232535 A DE69232535 A DE 69232535A DE 69232535 D1 DE69232535 D1 DE 69232535D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- hormone
- secretion
- insulin
- respond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0613—Cells from endocrine organs
- C12N5/0617—Thyroid and parathyroid glands
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Methods are provided for the establishment and maintenance in long term culture of hormone secreting cells. Cells are derived from tumorous or non-tumorous animal or human tissues, including ovary, endometrium, trophoblast, pituitary, thyroid, and pancreas. The cells secrete into the culture medium hormones such as estrogens, progestins, follicle-stimulating hormone, luteinizing hormone, human chorionic gonadotrophin, thyroxin, glucagon, and insulin, depending on the tissue of origin of individual cell cultures. Contact with an appropriate secretogogue causes the cells to respond with increased hormone secretion. For instance, ovarian follicular cells respond to follicle-stimulating hormone with increased estrogen and progesterone secretion. Pancreatic cells respond to elevated glucose with increased insulin secretion. The cells proliferate in in vitro for up to one year or longer, during which time they retain their hormone-secretion profile. The cells may be frozen for storage, and retain their hormone-secretion profile after thawing. The cell cultures are useful for the production of human hormones, for the bio-assay of drugs such as therapeutic gonadotrophin, for the testing of drug efficacy and design, and for toxicity testing of drugs and chemicals. The cells may also be implanted in an individual to replace deficient hormone secretion. For instance, insulin secreting pancreatic cells may be implanted in a diabetic individual as an adjunct or replacement therapy for exogenously administered insulin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71997791A | 1991-06-24 | 1991-06-24 | |
PCT/US1992/005267 WO1993000441A1 (en) | 1991-06-24 | 1992-06-23 | Hormone-secreting cells maintained in long-term culture |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69232535D1 true DE69232535D1 (en) | 2002-05-08 |
Family
ID=24892163
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69232535A Expired - Fee Related DE69232535D1 (en) | 1991-06-24 | 1992-06-23 | LONG-TERM CULTURE HORMONE-SECONDING PANCREATIC CELLS |
DE69232535T Expired - Lifetime DE69232535T4 (en) | 1991-06-24 | 1992-06-23 | LONG-TERM CULTURE HORMONE-SEPARATING PANCREATIC CELLS |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69232535T Expired - Lifetime DE69232535T4 (en) | 1991-06-24 | 1992-06-23 | LONG-TERM CULTURE HORMONE-SEPARATING PANCREATIC CELLS |
Country Status (10)
Country | Link |
---|---|
US (2) | US5928942A (en) |
EP (1) | EP0605428B9 (en) |
JP (1) | JPH06508527A (en) |
AT (1) | ATE215605T1 (en) |
AU (2) | AU2228592A (en) |
CA (1) | CA2112112A1 (en) |
DE (2) | DE69232535D1 (en) |
DK (1) | DK0605428T5 (en) |
ES (1) | ES2179821T3 (en) |
WO (1) | WO1993000441A1 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6231881B1 (en) | 1992-02-24 | 2001-05-15 | Anton-Lewis Usala | Medium and matrix for long-term proliferation of cells |
US6352707B1 (en) | 1992-02-24 | 2002-03-05 | Anton-Lewis Usala | Transplant encapsulation in a hydrogel matrix to obscure immune recognition |
US6008047A (en) * | 1993-04-08 | 1999-12-28 | Livercell L.L.C. | Cell culturing method and medium |
JP2813467B2 (en) * | 1993-04-08 | 1998-10-22 | ヒューマン・セル・カルチャーズ・インコーポレーテッド | Cell culture methods and media |
US5534404A (en) * | 1993-12-10 | 1996-07-09 | Cytotherapeutics, Inc. | Glucose responsive insulin secreting β-cell lines and method for producing same |
US5834308A (en) * | 1994-04-28 | 1998-11-10 | University Of Florida Research Foundation, Inc. | In vitro growth of functional islets of Langerhans |
US6703017B1 (en) | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
US6001647A (en) * | 1994-04-28 | 1999-12-14 | Ixion Biotechnology, Inc. | In vitro growth of functional islets of Langerhans and in vivo uses thereof |
US6485723B1 (en) | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
AU739771B2 (en) * | 1995-10-25 | 2001-10-18 | University Of Florida Research Foundation, Inc. | In vitro growth of functional islets of langerhans and in vivo uses thereof |
US6043092A (en) * | 1996-03-18 | 2000-03-28 | University Of Pittsburgh | Cell culture media for mammalian cells |
FR2757371B1 (en) * | 1996-12-20 | 1999-03-26 | Mxm | ELASTIC DEVICE WITH LARGE ELONGATION CAPACITY FOR LIVE TISSUE EXTENSION |
KR20000070879A (en) | 1997-02-06 | 2000-11-25 | 브루스 엠. 에이센, 토마스 제이 데스로저 | Human sdf-5 protein and compositions |
US6165748A (en) | 1997-07-11 | 2000-12-26 | Genetics Institute, Inc. | Frazzled nucleotide sequences and expression products |
US6074874A (en) * | 1997-08-29 | 2000-06-13 | University Of Pittsburgh | Epithelial cell cultures for in vitro testing |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US6866843B2 (en) * | 1999-12-06 | 2005-03-15 | Viacell, Inc. | Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell |
US20050042749A1 (en) | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
WO2001088104A2 (en) | 2000-05-17 | 2001-11-22 | Geron Corporation | Neural progenitor cell populations |
US6759039B2 (en) * | 2000-06-30 | 2004-07-06 | Amcyte, Inc. | Culturing pancreatic stem cells having a specified, intermediate stage of development |
AU2001273108A1 (en) * | 2000-06-30 | 2002-01-14 | Amcyte, Inc. | Culturing pancreatic stem cells having a specified, intermediate stage of development |
US6468989B1 (en) * | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
US7202080B2 (en) | 2001-03-29 | 2007-04-10 | Ixion Biotechnology, Inc. | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
US6642003B2 (en) | 2001-08-02 | 2003-11-04 | Cedars-Sinai Medical Center | Human glucose-dependent insulin-secreting cell line |
GB2415432B (en) * | 2001-12-07 | 2006-09-06 | Geron Corp | Islet cells from human embryonic stem cells |
US7101546B2 (en) * | 2001-12-21 | 2006-09-05 | Amcyte, Inc. | In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development |
US6881726B2 (en) * | 2001-12-24 | 2005-04-19 | Dow Pharmaceutical Sciences | Aqueous compositions containing metronidazole |
US7141240B2 (en) * | 2002-03-12 | 2006-11-28 | Cedars-Sinai Medical Center | Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1 |
US20050025838A1 (en) | 2003-06-25 | 2005-02-03 | Badylak Stephen F. | Conditioned compositions for tissue restoration |
JPWO2005110394A1 (en) * | 2004-05-19 | 2008-03-21 | 味の素株式会社 | Diabetes medicine |
CN100446051C (en) * | 2006-05-19 | 2008-12-24 | 刘芳 | Method for building external nidation model of embryo body and usage |
WO2007149182A2 (en) | 2006-06-19 | 2007-12-27 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
US8298586B2 (en) | 2009-07-22 | 2012-10-30 | Acell Inc | Variable density tissue graft composition |
DK2493922T3 (en) | 2009-10-26 | 2017-04-24 | Hoffmann La Roche | Process for preparing a glycosylated immunoglobulin |
US9878071B2 (en) | 2013-10-16 | 2018-01-30 | Purdue Research Foundation | Collagen compositions and methods of use |
WO2016172365A1 (en) | 2015-04-21 | 2016-10-27 | Purdue Research Foundation Office Of Technology Commercialization | Cell-collagen-silica composites and methods of making and using the same |
US20180140640A1 (en) * | 2015-04-22 | 2018-05-24 | Cadens Beheer B.V. | Improved contraceptive methods and compositions and devices for use therein |
CN106701659A (en) * | 2016-10-31 | 2017-05-24 | 四川农业大学 | Porcine ovarian granulosa cell primary culture method |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CA3061428A1 (en) | 2017-04-25 | 2018-11-01 | Purdue Research Foundation | 3-dimensional (3d) tissue-engineered muscle for tissue restoration |
CN112048540B (en) * | 2020-09-14 | 2022-10-11 | 北京大学 | Method for detecting insulin secretion in pancreatic islet and application thereof |
CN113398251B (en) * | 2021-07-30 | 2022-08-05 | 宁波人健药业集团股份有限公司 | Recombinant human chorionic gonadotropin freeze-dried powder injection and preparation method thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3882233A (en) * | 1973-07-27 | 1975-05-06 | American Home Prod | Methods of increasing production of pituitary hormones |
US4288546A (en) * | 1976-04-09 | 1981-09-08 | The Regents Of The University Of Minnesota | Process for the large scale production of pituitary hormones by serial secondary suspension culture |
US4439521A (en) * | 1981-10-21 | 1984-03-27 | Ontario Cancer Institute | Method for producing self-reproducing mammalian pancreatic islet-like structures |
US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
DK402984D0 (en) * | 1984-08-23 | 1984-08-23 | Nordisk Insulinlab | PROCEDURE FOR PROMOTING INSULIN-PRODUCING CELLS |
AU7281787A (en) * | 1986-04-01 | 1987-10-20 | Genelabs Incorporated | Immortalized cells which produce tissue-specific products |
DE3871206D1 (en) * | 1987-03-24 | 1992-06-25 | Grace W R & Co | BASIC MEDIUM FOR A CELL CULTURE. |
US4929542A (en) * | 1987-10-30 | 1990-05-29 | Cornell Research Foundation, Inc. | In vitro screening test for mutagenicity and genotoxicity during spermatogenesis |
US4980281A (en) * | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
EP0363125A3 (en) * | 1988-10-03 | 1990-08-16 | Hana Biologics Inc. | Proliferated pancreatic endocrine cell product and process |
US4983515A (en) * | 1989-02-16 | 1991-01-08 | E. I. Du Pont De Nemours And Company | Labeled cryopreserved cells for use as targets in cytotoxicity assays |
US4983527A (en) * | 1989-05-26 | 1991-01-08 | Arizona Board Of Regents | Oocyte test for detection of tumor promoting compounds |
US5328844A (en) * | 1990-05-09 | 1994-07-12 | University Of Colorado Foundation, Inc. | Culture media for mammalian cells |
JP2813467B2 (en) * | 1993-04-08 | 1998-10-22 | ヒューマン・セル・カルチャーズ・インコーポレーテッド | Cell culture methods and media |
US5534404A (en) * | 1993-12-10 | 1996-07-09 | Cytotherapeutics, Inc. | Glucose responsive insulin secreting β-cell lines and method for producing same |
-
1992
- 1992-06-23 DK DK92914162T patent/DK0605428T5/en active
- 1992-06-23 CA CA002112112A patent/CA2112112A1/en not_active Abandoned
- 1992-06-23 EP EP92914162A patent/EP0605428B9/en not_active Expired - Lifetime
- 1992-06-23 JP JP5501606A patent/JPH06508527A/en active Pending
- 1992-06-23 DE DE69232535A patent/DE69232535D1/en not_active Expired - Fee Related
- 1992-06-23 AT AT92914162T patent/ATE215605T1/en not_active IP Right Cessation
- 1992-06-23 WO PCT/US1992/005267 patent/WO1993000441A1/en active IP Right Grant
- 1992-06-23 AU AU22285/92A patent/AU2228592A/en not_active Abandoned
- 1992-06-23 DE DE69232535T patent/DE69232535T4/en not_active Expired - Lifetime
- 1992-06-23 ES ES92914162T patent/ES2179821T3/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/475,969 patent/US5928942A/en not_active Expired - Fee Related
-
1996
- 1996-10-23 AU AU70365/96A patent/AU700946B2/en not_active Ceased
-
1999
- 1999-04-28 US US09/301,110 patent/US6372493B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0605428B9 (en) | 2003-01-02 |
EP0605428A1 (en) | 1994-07-13 |
WO1993000441A1 (en) | 1993-01-07 |
CA2112112A1 (en) | 1993-01-07 |
US6372493B1 (en) | 2002-04-16 |
DK0605428T5 (en) | 2003-01-06 |
JPH06508527A (en) | 1994-09-29 |
DE69232535T2 (en) | 2003-01-09 |
ATE215605T1 (en) | 2002-04-15 |
AU2228592A (en) | 1993-01-25 |
EP0605428A4 (en) | 1995-01-11 |
ES2179821T3 (en) | 2003-02-01 |
AU700946B2 (en) | 1999-01-14 |
AU7036596A (en) | 1997-02-20 |
DK0605428T3 (en) | 2002-07-29 |
DE69232535T4 (en) | 2003-09-11 |
US5928942A (en) | 1999-07-27 |
EP0605428B1 (en) | 2002-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69232535D1 (en) | LONG-TERM CULTURE HORMONE-SECONDING PANCREATIC CELLS | |
Herbert | Localization of antisera to LHβ and FSHβ in the rat pituitary gland | |
Dozortsev et al. | Luteinizing hormone–independent rise of progesterone as the physiological trigger of the ovulatory gonadotropins surge in the human | |
ATE553766T1 (en) | PREPARATION AND XENOTRANSPLANTATION OF ISLANDS OF LANGERHANS FROM PIGS | |
NO320713B1 (en) | Pharmaceutical preparation comprising Sertoli cells and cells producing a biological factor, sectioned set of containers for the cells, product article comprising a packaging material with Sertoli cells and methods for increasing the recovery and profiling of cells ex vivo. | |
Fölsch et al. | Effect of somatostatin on basal and stimulated pancreatic secretion in the rat | |
Roser et al. | Superovulation in the mare: a work in progress | |
Hammond et al. | Local maintenance of the rabbit corpus luteum with oestrogen | |
WEICK et al. | Localization of the stimulatory feedback effect of estrogen on ovulation in the rat | |
Van Oordt et al. | Seasonal changes in endocrine organs of the male common frog, Rana temporaria: I. The pars distalis of the adenohypophysis | |
Korsgren et al. | Glucose effectiveness: the mouse trap in the development of novel ss-cell replacement therapies | |
McCracken | The role of prostaglandins in luteal regression | |
Bosu et al. | Effect of HCG on plasma levels of estrogens and progesterone during the luteal phase of the menstrual cycle in rhesus monkeys (Macaca mulatta). Stimulation of sex steroid production in rhesus monkeys | |
Kuzuya et al. | Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia | |
Moses et al. | Dissociation between the content of vasopressin and neurosecretory material in the rat neurohypophysis | |
Iyer et al. | Delta sleep inducing peptide (DSIP) stimulates the release of LH but not FSH via a hypothalamic site of action in the rat | |
Rennie | Luteal-hypophyseal interrelationship in the rabbit | |
CHOUDARY et al. | Luteolytic effect of oestrogen on the corpora lutea of the cyclic guinea-pig | |
De Castro et al. | Possible negative ultra-short loop feedback of luteinizing hormone releasing hormone (LHRH) in the ovariectomized rat | |
Gemmell et al. | Granule secretion by the luteal cell of the sheep: the fate of the granule membrane | |
Piacsek et al. | Stimulation by light of gonadotropin release from transplanted pituitaries of hypophysectomized rats | |
GREENWALD | Dissociation of Ovulation and Progesterone Secretion Following LH or FSH Treatment of Hypophysectomized Prbestrous Hamsters | |
Schatz et al. | Hypophysis and function of pancreatic islets. 3. Secretion and biosynthesis of insulin in isolated pancreatic islets of intact and hypophysectomized rats in the presence of growth hormone, corticotrophin and human chorionic somatotrophin in vitro | |
Foster Jr et al. | On the secretion of corticotrophin by the homotransplanted pituitary gland in the rat | |
Kullander | Experimental studies in the production of androgen in ovarian tissue autotransplanted to the spleen of spayed rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: HCELL TECHNOLOGY, INC., RENO, NV, US |
|
8328 | Change in the person/name/address of the agent |
Free format text: V. FUENER EBBINGHAUS FINCK HANO, 81541 MUENCHEN |
|
8339 | Ceased/non-payment of the annual fee |